Reducing the Harms of Nonclinical Psychedelics Use Through a Peer-Support Telephone Helpline.

Mollie M Pleet, Joshua White, Joseph A Zamaria, Rachel Yehuda
{"title":"Reducing the Harms of Nonclinical Psychedelics Use Through a Peer-Support Telephone Helpline.","authors":"Mollie M Pleet,&nbsp;Joshua White,&nbsp;Joseph A Zamaria,&nbsp;Rachel Yehuda","doi":"10.1089/psymed.2022.0017","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>A resurgence of interest in the use of psychedelics for mental health and wellness has stimulated greater experimentation with psychedelics in society. Although clinical psychedelic trials protect research participants by offering a safe setting, thorough preparation, and containment during and after ingestion of psychedelic medicines, many try these substances without the benefit of these safeguards.</p><p><strong>Materials and methods: </strong>We analyzed data gathered from 884 callers to a psychedelic helpline to determine whether a helpline model could reduce the risks associated with nonclinical psychedelics use.</p><p><strong>Results: </strong>In total, 65.9% of callers indicated that the helpline de-escalated them from psychological distress. If not for their conversation with the helpline, 29.3% of callers indicated they may have been harmed; 12.5% indicated that they may have called 911; and 10.8% indicated they may have gone to the emergency room.</p><p><strong>Conclusion: </strong>The data suggest that access to a psychedelic helpline surrounding psychedelic experiences may avert harmful outcomes and offset the burden on emergency and medical services.</p>","PeriodicalId":74590,"journal":{"name":"Psychedelic medicine (New Rochelle, N.Y.)","volume":"1 2","pages":"69-73"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286261/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychedelic medicine (New Rochelle, N.Y.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/psymed.2022.0017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: A resurgence of interest in the use of psychedelics for mental health and wellness has stimulated greater experimentation with psychedelics in society. Although clinical psychedelic trials protect research participants by offering a safe setting, thorough preparation, and containment during and after ingestion of psychedelic medicines, many try these substances without the benefit of these safeguards.

Materials and methods: We analyzed data gathered from 884 callers to a psychedelic helpline to determine whether a helpline model could reduce the risks associated with nonclinical psychedelics use.

Results: In total, 65.9% of callers indicated that the helpline de-escalated them from psychological distress. If not for their conversation with the helpline, 29.3% of callers indicated they may have been harmed; 12.5% indicated that they may have called 911; and 10.8% indicated they may have gone to the emergency room.

Conclusion: The data suggest that access to a psychedelic helpline surrounding psychedelic experiences may avert harmful outcomes and offset the burden on emergency and medical services.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过同伴支持电话热线减少非临床致幻剂使用的危害。
引言:对使用致幻剂促进心理健康和健康的兴趣的复苏刺激了社会上更多的致幻剂实验。尽管临床迷幻药试验通过在服用迷幻药期间和之后提供安全的环境、彻底的准备和控制来保护研究参与者,但许多人在没有这些保障措施的情况下尝试这些物质。材料和方法:我们分析了从884个迷幻药求助热线收集的数据,以确定求助热线模式是否可以降低与非临床使用迷幻药相关的风险。结果:65.9%的来电者表示求助热线缓解了他们的心理困扰。如果不是因为他们与热线电话的对话,29.3%的来电者表示他们可能会受到伤害;12.5%的人表示他们可能拨打过911;10.8%的人表示他们可能去过急诊室。结论:数据表明,在迷幻经历周围拨打迷幻求助热线可以避免有害后果,减轻急救和医疗服务的负担。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Ketamine-Occasioned Mystical Experience in Veterans with Treatment-Resistant Depression: A Retrospective Exploratory Analysis. Overview and Specificity of Psilocybin Use in the Treatment of Mental Disorders: A Scientometric Analysis. Systematic Review of the Effect of Psychedelic-Assisted Therapy on Attitudes Toward Death, Life, and Spirituality on Symptoms of Distress, Depression, and/or Anxiety in Patients with Life-Threatening Illness. What is Psychological Support in the Context of Psychedelic Clinical Trials? Ketamine-Assisted Group Therapy for Work-Related Stress in First Responders and Frontline Health Care Workers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1